Neurotech, Inc.
United StatesFDA applicant, unverified
- Devices
- 3
What Neurotech, Inc. makes
Neurotech, Inc. manufactures neuromuscular stimulators and associated control systems, including programmable units like the NEUROTECH-16 PROGRAM SYSTEM CONTROLLER MODEL 280 and the NEUROTECH-4 PROGRAM NEUROMUSCULAR STIMULATOR 281. Their portfolio also includes devices designed for action potential simulation therapy, intended for targeted neuromuscular or nerve stimulation applications.
These devices are classified under Class II in the US regulatory framework and are listed via the FDA’s 510(k) pathway. The company operates from the United States, adhering to domestic medical device regulations.
Catalogue
Neurotech-16 Program System Controller Model 280 Ref K860315
Regimes: 510(k) Registry: 510(k)Neurotech-4 Program Neuromuscular Stimulator 281 Ref K860314
Regimes: 510(k) Registry: 510(k)Action Potential Simulation Therapy Device Ref K955470
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Neurotech, Inc. have in the registry?
The registry currently lists 3 devices for Neurotech, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neurotech, Inc.'s devices?
Among its 3 most recently registered devices, Neurotech, Inc. has devices listed in FDA 510(k) (3 devices).
What risk classes do Neurotech, Inc.'s devices fall under?
Among its 3 most recently registered devices, the classes recorded for Neurotech, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neurotech, Inc. in the registry?
The most recently registered devices listed for Neurotech, Inc. include NEUROTECH-16 PROGRAM SYSTEM CONTROLLER MODEL 280, NEUROTECH-4 PROGRAM NEUROMUSCULAR STIMULATOR 281 and ACTION POTENTIAL SIMULATION THERAPY DEVICE.